Notice Number: NOT-CA-05-022
Release Date: June 10, 2005
The NATIONAL CANCER INSTITUTE (NCI) is requesting project proposals in response to the Rapid Access to Intervention Development (RAID) program. The RAID program will make available to academic investigators, on a competitive basis, the preclinical development contract resources of NCI's Developmental Therapeutics Program (DTP). RAID is not a grant program. Proposed projects that are approved for access to the resources of RAID gain access to the drug development contract resources of the Developmental Therapeutics Program. The goal of RAID is the rapid movement of novel molecules and concepts from the laboratory to the clinic for proof-of-principle clinical trials. RAID will assist investigators who submit successful project proposals by providing any (or all) of the preclinical development steps that may be obstacles to clinical translation. Possible tasks may include production, bulk supply, good manufacturing process (GMP) manufacturing, formulation, and toxicology. Suitable agents for RAID will include small molecules, biologics, or vaccines.
There are two receipt dates, February 1 and August 1, for requests for RAID support per year. Investigators must submit a 1- 2 page statement of interest that describes the minimal essential details of proposed project at least 15 days before the deadline. Complete descriptions of the proposed projects must be received by August 1, 2005, with all required materials submitted directly to the office listed below.
For information on the procedure for requesting RAID resources, visit the DTP web site http://dtp.nci.nih.gov/. Inquiries are encouraged and DTP staff welcomes opportunities to clarify issues or answer questions about the RAID program. Academic investigators may have collaborations with small-business partners and still qualify for RAID funding. Non-profit organizations other than universities may also submit project proposals to RAID. Please note that a maximum of two distinct requests for support per investigator can be submitted for each receipt date.
Inquiries regarding this notice may be directed to:
Office of Associate Director
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
6130 Executive Blvd., EPN Suite 8022, MSC 7458
Bethesda, MD 20892-7458 (U.S. mail)
Rockville, MD 20852 (for express/courier service)
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.